Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What is the best use of company capital?

"That increase in the Authorized count would have not been made if there was not a strategy in mind to eventually utilize those shares, either as a corporate financing mechanism for M&As, or for building our cash reserves through a Secondary or by some Convertable Debt instrument.

Bottom line ... expect more shares to be issued, not a net reduction in shares."

__________________________________________________________________

You are 100% correct. I can't believe someone hasn't mentioned this before now, myself included. My experience with companies asking for more authorized shares is actually as you've describe. They plan to use them eventually. Sad but true. Hope I (and you) am wrong. Maybe it's there for the new blood that'll be coming to the BoD (kidding).

If there is a positive side to our current situation, imo, it's the sp. (I know I'll get flak on that comment). I'm not saying the low sp is a good thing but what I am saying is, I do believe the sp is reflective of the 336 as being 'final rejected' and the MMP as a whole a hundred fold weaker and non effective as a revenue stream. Remove the USPTO cloud cover and get the re-certs. Get the MMP pipeline full again with steady stream of licenses being sold and the sp will respond accordingly. Of course, all this that I'm typing, everyone already knows anyway. This post is no revelation. I'm just trying to stay positive in what has been a very difficult and dismal journey of an investment. Maybe, just maybe 336 will get the nod from the PTO and PTSC will soon see substantial revs. It's time for the shareholders to catch a break. It's actually past time.

GLTA,
PxP

ps. btw, nice post

Share
New Message
Please login to post a reply